TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: A midwest-southwest consortium for FTLD study

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 4, 2008, Pages 271-279

  Hatanpaa, Kimmo J ^a   Bigio, Eileen H ^b   Cairns, Nigel J ^c   Womack, Kyle B ^a   Weintraub, Sandra ^b   Morris, John C ^c   Foong, Chan ^a   Xiao, Guanghua ^a   Hladik, Christa ^a   Mantanona, Tina Y ^a   White III, Charles L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dementia lacking distinctive histopathology; Dystrophic neurites; Frontotemporal lobar degeneration with motor neuron disease; Frontotemporal lobar degeneration with ubiquitinated inclusions; Immunohistochemistry; Progranulin; TAR DNA binding protein 43

Indexed keywords

NUCLEAR PROTEIN; TAR DNA BINDING PROTEIN 43; UNCLASSIFIED DRUG;

AGED; ARTICLE; AUTOPSY; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DYSTROPHY; FEMALE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEURITE; PRIORITY JOURNAL; STAINING;

AGED; AUTOPSY; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEURITES; SENILE PLAQUES; TAU PROTEINS; UBIQUITIN;

EID: 41949132982     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31816a12a6     Document Type: Article

References (28)

1. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996;5:339-50
2. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl) 2007;114:5-22
3. Lipton AM, White CL, 3rd, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004;108:379-85
4. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-33
5. Davidson Y, Kelley T, Mackenzie IR, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol (Berl) 2007;113:521-33
6. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-19
7. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442:920-94
8. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988-3001
9. Mukherjee O, Pastor P, Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 2006;60:314-22
10. Giannakopoulos P, Hof PR, Bouras C. Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases. Acta Neuropathol (Berl) 1995;89:346-55
11. Knopman DS, Mastri AR, Frey WH, 2nd, et al. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia. Neurology 1990;40:251-56
12. Corey-Bloom J, Sabbagh MN, Bondi MW, et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 1997;48:154-60
13. Jellinger KA. Hippocampal sclerosis: A common pathological feature of dementia in very old humans. Acta Neuropathol (Berl) 1994;88:599
14. Blass DM, Hatanpaa KJ, Brandt J, et al. Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology 2004;63:492-97
15. Hatanpaa KJ, Blass DM, Pletnikova O, et al. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 2004;63:538-42
16. Mackenzie IR, Shi J, Shaw CL, et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol (Berl) 2006;112:551-59
17. Josephs KA, Dickson DW. Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration. Neurobiol Aging 2007;28:1718-22
18. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-44
19. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56:1095-97
20. Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007;171:227-40
21. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-52
22. Lowry R. VassarStats: Web Site for Statistical Computation. Poughkeepsie, NY: Vassar College, 1998
23. Agresti A. Introduction to Categorical Data Analysis. New York: John Wiley and Sons, 1996
24. Nakano I. Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology 2000;20:68-75
25. Russo D, Ambrosino A, Vittoria A, et al. Signal amplification by combining two advanced immunohistochemical techniques. Eur J Histochem 2003;47:379-84
26. Qvigstad G, Sandvik AK, Brenna E, et al. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique. Histochem J 2000;32:551-56
27. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-8
28. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61:435-45